Copyright
©The Author(s) 2016.
World J Diabetes. Oct 15, 2016; 7(18): 423-432
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.423
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.423
Figure 2 Intima media thickness, endogenous receptor for advanced glycation end-products, S100A12 and 5-hydroxyvitamin D according to glucose tolerance and glycated haemoglobin levels.
A: IMT, aP < 0.05 vs CTRL; B: esRAGE, aP < 0.05 vs CTRL; C: S100A12, aP < 0.05 vs CTRL; D: 25(OH)D, aP < 0.05 vs CTRL. IMT: Intima-media thickness; esRAGE: Endogenous receptor for advanced glycation end-products; 25(OH)D: 25-hydroxyvitamin D; NFG: Normal fasting glucose; NGT: Normal glucose tolerance; IFG: Impaired fasting glucose; IGT: Impaired glucose tolerance; T2DM: Type 2 diabetes mellitus; HbA1c: Glycated haemoglobin.
- Citation: Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM. Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk. World J Diabetes 2016; 7(18): 423-432
- URL: https://www.wjgnet.com/1948-9358/full/v7/i18/423.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i18.423